Oral Session 1-9A Malignant Lymphoma: Diagnosis/Comorbidity/Others

[OS1-9A-2] Mortality of non-Hodgkin lymphoma in rituximab era: a population-based analysis in the US and Japan

Yoshiaki Usui^1,3, Hidemi Ito¹, Yuriko Koyanagi¹, Tomohiro Matsuda², Kota Katanoda², Yoshinobu Maeda³, Keitaro Matsuo⁴ (1.Cancer Information and Control, Aichi Cancer Center, Aichi, Japan, 2.Cancer Control and Information Services, National Cancer Center, Tokyo, Japan, 3.Hematology, Oncology and Respiratory Medicine, Okayama University, Okayama, Japan, 4.Cancer Epidemiology and Prevention, Aichi Cancer Center, Aichi, Japan)